Home APPROVALS Page 2

APPROVALS

FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy
APPROVALS

FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy

Tess Egginton -
0
FDA approves RIABNI (rituximab-arrx), a biosimilar to Rituxan (rituximab), for adults with moderate to severe rheumatoid arthritis
APPROVALS

FDA approves RIABNI (rituximab-arrx), a biosimilar to Rituxan (rituximab), for adults with moderate to severe rheumatoid arthritis

Tess Egginton -
0
FDA approves first treatment for eosinophilic esophagitis, a chronic immune disorder
APPROVALS

FDA approves first treatment for eosinophilic esophagitis, a chronic immune disorder

Tess Egginton -
0
WHO validates 11th vaccine for COVID-19
APPROVALS

WHO validates 11th vaccine for COVID-19

Tess Egginton -
0
MHRA approves faricimab for progressive eye diseases through international work-sharing initiative
APPROVALS

MHRA approves faricimab for progressive eye diseases through international work-sharing initiative

Tess Egginton -
0
FDA approves Lilly’s Mounjaro injection for type 2 diabetes
APPROVALS

FDA approves Lilly’s Mounjaro injection for type 2 diabetes

Tess Egginton -
0
FDA approves Lilly and Incyte’s OLUMIANT (baricitinib) for hospitalized patients with COVID-19
APPROVALS

FDA approves Lilly and Incyte’s OLUMIANT (baricitinib) for hospitalized patients with COVID-19

Tess Egginton -
0
Enhertu approved in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen
APPROVALS

Enhertu approved in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen

Tess Egginton -
0
Novartis receives European Commission approval for Jakavi to be the first post-steroid treatment for acute and chronic graft-versus-host disease
APPROVALS

Novartis receives European Commission approval for Jakavi to be the first post-steroid treatment for acute and chronic graft-versus-host disease

Tess Egginton -
0
RINVOQ approved by U.S. FDA as an oral treatment for adults with active ankylosing spondylitis
APPROVALS

RINVOQ approved by U.S. FDA as an oral treatment for adults with active ankylosing spondylitis

Tess Egginton -
0
123...10Page 2 of 10

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks